ArticleInvestigative ophthalmology & visual science2026
Parafoveal Dark Adaptation in Early and Intermediate Age-Related Macular Degeneration.
Article in Investigative ophthalmology & visual science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07515521 (Enhanced Vision and Imaging Tests for Enabling Treatment Trials in Early and Intermediate AMD), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Enhanced Vision and Imaging Tests for Enabling Treatment Trials in Early and Intermediate AMD
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Rod-mediated dark adaptation delays are among the earliest functional abnormalities in age-related macular degeneration (AMD), preceding photoreceptor loss. This study evaluated whether parafoveal fundus-tracked dark adaptometry at 2 degrees detects earlier rod dysfunction than mid-macular loci (4 degrees and 6 degrees) and assessed the diagnostic performance of dynamic and steady-state parameters across eccentricities. Methods: In this cross-sectional study, 35 patients with predominantly early/intermediate AMD and 35 healthy volunteers across a broad range of ages underwent fundus-controlled dark adaptometry (S-MAIA-2; iCare/CenterVue) and multimodal imaging. After standardized bleaching, Goldmann III sized (0.43 degrees) cyan stimuli were presented 2 degrees, 4 degrees, and 6 degrees temporal to the fovea. Dark-adaptation curves were modeled to derive rod intercept time (RIT), final (rod) threshold (FT), and cone threshold (CT), each compared with normative data. Diagnostic accuracy was quantified using covariate-adjusted receiver operating characteristic (ROC) analyses, to account for age. Results: Among 70 analyzed eyes, RIT was abnormal in 86% of AMD eyes at 2 degrees, 69% at 4 degrees, and 60% at 6 degrees, whereas FT and CT were less frequently abnormal (29% to 51% and 17% to 26%, respectively). Median RIT at 2 degrees reached 60 minutes in the AMD cohort, indicating absence of rod function within the test duration in many eyes. RIT achieved the highest diagnostic accuracy, with covariate-adjusted area under the curve (AUC) values of 0.91 (95% credible intervals [CrI] = 0.80-0.97) at 2 degrees, 0.88 (95% CrI = 0.77-0.96) at 4 degrees, and 0.87 (95% CrI = 0.76-0.95) at 6 degrees. Conclusions: Fundus-tracked dark adaptometry enables spatially precise assessment of parafoveal rod recovery. Parafoveal RIT prolongation represents the earliest and most frequent functional abnormality in AMD and demonstrates excellent diagnostic performance, supporting its potential as a sensitive functional biomarker for early disease and therapeutic trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.